Transfusional Iron Overload

Showing 1 - 13 of 13

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Transfusional Iron Overload, Beta-Thalassemia Trial in Worldwide (SPD602)

Terminated
  • Transfusional Iron Overload
  • Beta-Thalassemia
  • Boston, Massachusetts
  • +8 more
Jun 10, 2021

Transfusional Iron Overload, Beta-thalassemia Trial in Worldwide (SPD602 (FBS0701, SSP-004184))

Completed
  • Transfusional Iron Overload
  • Beta-thalassemia
  • SPD602 (FBS0701, SSP-004184)
  • Oakland, California
  • +8 more
May 30, 2021

Transfusional Iron Overload, Iron Overload, Iron Chelation Trial (SPD602, Deferasirox)

Withdrawn
  • Transfusional Iron Overload
  • +6 more
  • (no location specified)
Jun 1, 2021

ß-thalassemia, Transfusional Iron Overload Trial in Cagliari, Genova, Orbassano (Deferasirox)

Completed
  • β-thalassemia
  • Transfusional Iron Overload
  • Cagliari, CA, Italy
  • +2 more
Dec 6, 2020

Myelodysplastic Syndrome, Transfusional Iron Overload Trial in Worldwide (Deferasirox)

Terminated
  • Myelodysplastic Syndrome
  • Transfusional Iron Overload
  • Caen, Cedex, France
  • +9 more
Mar 1, 2017

Hemoglobinopathies, MDS, Other Inherited or Acquired Anaemia Trial in Australia (deferasirox)

Completed
  • Hemoglobinopathies
  • +6 more
  • Adelaide, Australia
  • +3 more
Feb 20, 2017

Transfusional Iron Overload Trial in Greece, Italy, United States (ICL670)

Completed
  • Transfusional Iron Overload
  • Oakland, California
  • +17 more
Feb 21, 2017

High-Tc Susceptometer to Monitor Transfusional Iron Overload

Completed
  • Transfusional Iron Overload
  • +4 more
  • Hepatic biomagnetic susceptibility measurement
  • New York, New York
    Columbia University Medical Center
Sep 20, 2016

Transfusional Iron Overload Trial in Italy (Deferasirox)

Completed
  • Transfusional Iron Overload
  • Cagliari, Italy
  • +3 more
Mar 18, 2015

Transfusional Iron Overload, Transfusional Hemosiderosis Trial in Worldwide (Core Study: Deferasirox, Core Study: Deferoxamine,

Completed
  • Transfusional Iron Overload
  • Transfusional Hemosiderosis
  • Core Study: Deferasirox
  • +5 more
  • Toronto, Ontario, Canada
  • +20 more
Aug 13, 2014

Active Drug Surveillance Program of Ferriprox Use

Completed
  • Transfusional Iron Overload
    • Nicosia, Cyprus
    • +13 more
    Apr 19, 2013

    Transfusional Iron Overload, Beta-thalassemia Trial in Australia, Thailand, United States (FBS0701)

    Completed
    • Transfusional Iron Overload
    • Beta-thalassemia
    • Oakland, California
    • +4 more
    Feb 8, 2012